Bausch Health Companies Inc
BHC5.745USD
+0.035+0.61%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
2.12BCap. mercado
PérdidaP/E TTM
Más Datos de Bausch Health Companies Inc Compañía
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
Información de la empresa
Símbolo de cotizaciónBHC
Nombre de la empresaBausch Health Companies Inc
Fecha de salida a bolsaSep 20, 1994
Director ejecutivoMr. Thomas J. Appio
Número de empleados20700
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 20
Dirección2150 St. Elzear Blvd. West
CiudadLAVAL
Bolsa de valoresThe Toronto Stock Exchange
PaísCanada
Código postalH7L 4A8
Teléfono18003611448
Sitio Webhttps://www.bauschhealth.com/
Símbolo de cotizaciónBHC
Fecha de salida a bolsaSep 20, 1994
Director ejecutivoMr. Thomas J. Appio
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
627.22K
-24.81%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
264.39K
+0.39%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
254.72K
+27.12%
Mr. Steven D. Miller
Mr. Steven D. Miller
Independent Director
Independent Director
239.22K
+29.40%
Mr. Brett M. Icahn
Mr. Brett M. Icahn
Independent Director
Independent Director
225.40K
+1.82%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
30.15K
--
Mr. Michael Goettler
Mr. Michael Goettler
Director
Director
30.15K
--
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
8.11K
--
Dr. Richard C. Mulligan, Ph.D.
Dr. Richard C. Mulligan, Ph.D.
Independent Director
Independent Director
--
--
Mr. John A. Paulson
Mr. John A. Paulson
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
627.22K
-24.81%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
264.39K
+0.39%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
254.72K
+27.12%
Mr. Steven D. Miller
Mr. Steven D. Miller
Independent Director
Independent Director
239.22K
+29.40%
Mr. Brett M. Icahn
Mr. Brett M. Icahn
Independent Director
Independent Director
225.40K
+1.82%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
30.15K
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmaceutical Products
4.40B
45.67%
Device Products
2.24B
23.27%
OTC
1.90B
19.77%
Branded and Other Generic Products
979.00M
10.17%
Other Product Lines
107.00M
1.11%
Por regiónUSD
Nombre
Ganancia
Proporción
United States and Puerto Rico
5.77B
59.92%
Other Foreign Countries
1.08B
11.25%
China (Country)
496.00M
5.15%
Canada
402.00M
4.18%
Poland
350.00M
3.64%
Other
1.53B
15.86%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmaceutical Products
4.40B
45.67%
Device Products
2.24B
23.27%
OTC
1.90B
19.77%
Branded and Other Generic Products
979.00M
10.17%
Other Product Lines
107.00M
1.11%
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Meruelo (Alex)
9.94%
Icahn Associates Corporation
9.39%
Paulson & Co. Inc.
8.87%
GoldenTree Asset Management, LP
8.18%
Nomura Securities Co., Ltd.
6.33%
Other
57.29%
Accionistas
Accionistas
Proporción
Meruelo (Alex)
9.94%
Icahn Associates Corporation
9.39%
Paulson & Co. Inc.
8.87%
GoldenTree Asset Management, LP
8.18%
Nomura Securities Co., Ltd.
6.33%
Other
57.29%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
16.44%
Investment Advisor/Hedge Fund
16.30%
Individual Investor
11.04%
Family Office
8.87%
Research Firm
8.65%
Investment Advisor
8.64%
Bank and Trust
4.41%
Pension Fund
4.26%
Private Equity
1.42%
Other
19.98%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
514
263.21M
71.22%
-46.16M
2025Q1
547
263.71M
71.37%
-49.89M
2024Q4
568
275.73M
74.96%
-32.06M
2024Q3
627
279.89M
77.25%
-44.78M
2024Q2
703
283.62M
78.54%
-59.67M
2024Q1
764
278.87M
76.11%
-93.72M
2023Q4
801
283.62M
78.55%
-85.16M
2023Q3
821
301.23M
82.72%
-52.06M
2023Q2
836
283.61M
80.53%
-76.52M
2023Q1
862
290.05M
79.80%
-77.57M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Meruelo (Alex)
36.76M
9.95%
+148.73K
+0.41%
Mar 31, 2025
Icahn Associates Corporation
34.72M
9.4%
--
--
May 20, 2025
Paulson & Co. Inc.
32.79M
8.87%
+6.35M
+24.03%
Jun 13, 2025
GoldenTree Asset Management, LP
30.25M
8.19%
+2.71M
+9.84%
Mar 31, 2025
Nomura Securities Co., Ltd.
23.39M
6.33%
+12.05M
+106.21%
Mar 31, 2025
Healthcare Of Ontario Pension Plan
13.00M
3.52%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
11.68M
3.16%
+61.62K
+0.53%
Mar 31, 2025
National Bank of Canada
7.51M
2.03%
-7.91M
-51.29%
Mar 31, 2025
Maple Rock Capital Partners, Inc.
6.80M
1.84%
+1.50M
+28.25%
Mar 31, 2025
Macquarie Investment Management Global Ltd.
6.60M
1.79%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Gotham 1000 Value ETF
0.18%
VanEck Pharmaceutical ETF
0.14%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
0.12%
JPMorgan International Value ETF
0.09%
Schwab International Small-Cap Equity ETF
0.08%
iShares Intl Small Cap Equity Factor ETF
0.06%
DFA Dimensional International Small Cap ETF
0.05%
Schwab Fundamental International Equity ETF
0.04%
Invesco RAFI Developed Mkts ex-US ETF
0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
Ver más
Gotham 1000 Value ETF
Proporción0.18%
VanEck Pharmaceutical ETF
Proporción0.14%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
Proporción0.12%
JPMorgan International Value ETF
Proporción0.09%
Schwab International Small-Cap Equity ETF
Proporción0.08%
iShares Intl Small Cap Equity Factor ETF
Proporción0.06%
DFA Dimensional International Small Cap ETF
Proporción0.05%
Schwab Fundamental International Equity ETF
Proporción0.04%
Invesco RAFI Developed Mkts ex-US ETF
Proporción0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
